E25Bio Lands $2M Seed Funding Back to HomeCAMBRIDGE, MA, E25Bio Raises $2M From Khosla Ventures.
E25Bio, innovators of rapid diagnostic tests, announced today that it has raised a $2 million financing from Khosla Ventures.
"In this time of crisis we need every effort to get testing at scale on the market," said Vinod Khosla, founder of Khosla Ventures.
"The same way a hormone is detected on a pregnancy test, our diagnostics provides doctors and patients with results in 15 minutes or less," says Dr. Bosch, CTO of E25Bio.
The new funding will go towards research and development, clinical studies, and scaling the company's launch for diagnostic tests upon receiving EUA approval. | To read full story, visit https://startuparound.com/read/1584543606.8623552/E25Bio-Lands-$2M-Seed-Funding?ref=audio_experience